JP2007066283A - Commercial medical record - Google Patents
Commercial medical record Download PDFInfo
- Publication number
- JP2007066283A JP2007066283A JP2005291705A JP2005291705A JP2007066283A JP 2007066283 A JP2007066283 A JP 2007066283A JP 2005291705 A JP2005291705 A JP 2005291705A JP 2005291705 A JP2005291705 A JP 2005291705A JP 2007066283 A JP2007066283 A JP 2007066283A
- Authority
- JP
- Japan
- Prior art keywords
- medicine
- computer system
- medical record
- electronic medical
- disease name
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims abstract description 31
- 201000010099 disease Diseases 0.000 claims abstract description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims description 21
- 239000012567 medical material Substances 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 1
Images
Landscapes
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
本発明は、医師に対して、ピンポイントのタイミングで薬剤(取引者・需要者の間で医薬品として取り扱われ、取引の対象になっている薬品を意味する。以下同様)・医材・検査等の宣伝を行う為のコンピュータシステムに関する。The present invention provides medicine to a doctor at a pinpoint timing (meaning a medicine that is handled as a medicine between a trader and a consumer and is a subject of trade. The same applies hereinafter), medical supplies, examinations, etc. It relates to a computer system for advertising.
医師による手書きカルテを基に、そのデータをキーパンチャーがコンピュータに入力して請求書を作成していた時代があった。しかし今や、電子カルテの出現によって、医師が直接カルテのデータをコンピュータに入力することが可能になった。There was a time when a key puncher entered the data into a computer and created an invoice based on a doctor's handwritten medical record. However, with the advent of electronic medical records, doctors can now directly enter medical record data into computers.
従来、製薬会社を初めとする医療関係者にとって、何らかの伝達・宣伝をするのに、医師の診療時間中は最も好タイミングであるにも関わらず、不可侵の領域であった。Conventionally, for medical personnel such as pharmaceutical companies, it has been an inviolable area, although it is the best time during the doctor's consultation time to communicate and promote something.
電子カルテへの入力作業を効率化する、というのではなく、電子カルテをいかに活用するかについては、
医師に対して、ピンポイントのタイミングで薬剤・医材・検査等の宣伝を行う。Advertise doctors, medical supplies, and tests at a pinpoint timing.
先述の、医師によって直接入力するという電子カルテの特性を生かし、Taking advantage of the characteristics of electronic medical records that are directly input by doctors,
のように、医師が治療を開始する矢先に、入力された病名に呼応して、薬剤・医材・検査等に関する宣伝枠が電子カルテ画面上に表示されるコンピュータシステムを発明した。As described above, a computer system was invented in which an advertising frame concerning drugs, medical materials, examinations, and the like is displayed on the electronic medical chart screen in response to the input disease name at the point where the doctor starts treatment.
更に、上記In addition, the above
において、他に禁忌な病名を有している、或いは禁忌な薬剤を投薬中の場合は、その名称を表示しない、又は警告する措置を自動的にとる機能も付与した。In addition, when a contraindicated disease name or other contraindicated drug is being administered, a function of automatically displaying the name or warning is given.
また、Also,
のように、医師が電子カルテ入力を全く行わない状態で一定時間経過すると、次に何らかの入力イベントが発生する迄の間、電子カルテ画面を、特定患者の病名を意識しない薬剤・医材・検査等の宣伝の画面に切り替え、表示するコンピュータシステムを発明した。As shown in the above, if a doctor does not perform electronic medical record input for a certain period of time, until the next input event occurs, the electronic medical record screen will not be conscious of the specific patient's disease name. Invented a computer system that switches to and displays advertising screens.
製薬会社を初めとする医療関係者にとっては、自社製品を効率よく宣伝できるのは大きな利点といえ、このコンピュータシステムが、延いては医療費のコストダウンに貢献する可能性も考えられる。また、製薬会社から医療機関に対して、薬効・併用薬・副作用等を含む質の高い情報提供がピンポイントのタイミングで頻繁になされることで、医療サービスにおける質の向上の一助ともなりうる。For medical professionals such as pharmaceutical companies, it is a great advantage to be able to advertise their products efficiently, and this computer system may also contribute to reducing the cost of medical care. In addition, high quality information including drug effects, concomitant drugs, side effects, etc. is frequently provided from a pharmaceutical company to a medical institution at a pinpoint timing, which can help improve the quality of medical services.
・・
のように、電子カルテの画面上部・或いは左側4分の1程度を外枠とし、それを6分割して内枠とする。As shown above, the upper or left quarter of the screen of the electronic medical record is used as the outer frame, and it is divided into six as the inner frame.
のように、待機メモリーのソートキーの第一項において、入力したばかりを「0」とし、その他は「1」と設定しておく。入力されたばかりの病名を薬効とする製品を、As described above, in the first item of the sort key of the standby memory, “0” is set just for input, and “1” is set for the others. A product that has the medicinal properties of the disease name just entered,
・・
中「スポット1」から順に表示する。Display in order starting from “Spot 1”.
宣伝主は、宣伝したい薬剤・医材・検査等の名称、その効能にあたる病名、服薬にあたっての禁忌の病名・薬剤等、例えば以下に示すような内容を、予め電子カルテソフト提供側に情報提供する。電子カルテソフト提供側は、これを宣伝プログラムのデータとして暗号化し、電子カルテソフト同様にホームページ上に登録しておく。
▲1▼インターネットアドレス
▲2▼薬剤コード
▲3▼薬剤名
▲4▼会社名
▲5▼薬効・・・連続する3文字以上の病名を、最高3個まで登録する。
▲6▼薬剤一般名称
▲7▼禁忌病名・・・連続する3文字以上の病名を、最高5個まで登録する。
▲8▼禁忌薬剤・・・薬剤一般名称を、最高5個まで登録する。
▲9▼投薬上の注意事項Advertisers provide information to the electronic medical record software provider in advance on the names of drugs, medical materials, tests, etc. that they want to advertise, the names of their illnesses, the names of contraindicated diseases and drugs, etc. . The electronic medical record software provider encrypts this as advertisement program data and registers it on the homepage in the same manner as the electronic medical record software.
(1) Internet address (2) Drug code (3) Drug name (4) Company name (5) Drug effect: Up to 3 consecutive disease names with more than 3 letters are registered.
(6) Drug general name (7) Contraindicated disease name: Up to 5 consecutive disease names with 3 or more letters are registered.
(8) Contraindicated drugs: Register up to 5 general drug names.
▲ 9 ▼ Precautions for medication
宣伝主はそれぞれのホームページ上の▲1▼インターネットアドレス上に予め決められた範囲での宣伝用フォームを作成し、それをアップロードしておく。The advertiser creates (1) an advertisement form within a predetermined range on the Internet address on each homepage and uploads it.
のように、診察時、医師がカルテ画面に患者の病名を入力すると、それに呼応して、効能病名としての漢字3文字×3セットを順にコンピュータが検索する。該当する薬剤・医材・検査等がシステムに登録されていた場合、禁忌の病名・薬剤の有無を自動的に確認した上で、その薬剤・医材・検査等の名称を前述の宣伝用内枠に掲載する。As described above, when the doctor inputs the patient's disease name on the medical chart screen at the time of the examination, the computer sequentially searches for three kanji characters × 3 sets as the name of the effective disease in response to it. If the corresponding drug / medical material / inspection is registered in the system, the name of the drug / medical material / inspection etc. will be included in the above-mentioned promotion Post in the frame.
入力が行われない状態で一分経過した時、特定患者の病名を意識しない薬剤・医材・検査等の宣伝が電子カルテ画面全体に掲載される。When one minute has passed without any input, advertisements for drugs, medical supplies, examinations, etc. that are not conscious of the specific patient's disease name are displayed on the entire electronic medical record screen.
まず、この電子カルテのソフトをインターネット上に上げ、各医療機関が無料でダウンロードして使用できるようにし、普及を図る。それと並行して宣伝主を公募する。宣伝主・宣伝内容が、特定企業、特定薬剤・医材・検査等に偏らないことを旨とする。First, the electronic medical record software will be uploaded to the Internet so that each medical institution can download and use it free of charge. At the same time, the advertisers are recruited. Advertisers / advertising content should not be biased toward specific companies, specific drugs / medical materials / tests, etc.
同一薬効に係る、異なる製薬会社の薬剤名称を複数登録して、効果的なディスプレイを企図することも可能である。もちろん同一薬剤で複数のスポット画面宣伝を行うことも出来る。It is also possible to register a plurality of drug names of different pharmaceutical companies with the same medicinal effect and to design an effective display. Of course, multiple spot screens can be promoted with the same medicine.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005291705A JP2007066283A (en) | 2005-09-01 | 2005-09-01 | Commercial medical record |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005291705A JP2007066283A (en) | 2005-09-01 | 2005-09-01 | Commercial medical record |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007066283A true JP2007066283A (en) | 2007-03-15 |
JP2007066283A5 JP2007066283A5 (en) | 2008-09-11 |
Family
ID=37928346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005291705A Pending JP2007066283A (en) | 2005-09-01 | 2005-09-01 | Commercial medical record |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2007066283A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002032654A (en) * | 2000-07-17 | 2002-01-31 | Osaka Gas Co Ltd | Method and system for advertisement presentation and recording medium |
JP2003030523A (en) * | 2001-07-10 | 2003-01-31 | Usac System Kk | Information providing system |
-
2005
- 2005-09-01 JP JP2005291705A patent/JP2007066283A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002032654A (en) * | 2000-07-17 | 2002-01-31 | Osaka Gas Co Ltd | Method and system for advertisement presentation and recording medium |
JP2003030523A (en) * | 2001-07-10 | 2003-01-31 | Usac System Kk | Information providing system |
Non-Patent Citations (8)
Title |
---|
CSND199700333006, 岡 壽士, "画像データを含む電子カルテ・システム", 医療とコンピュータ Medical Care & Computer, 19970919, 第8巻, 第32−36頁, JP, 株式会社日本電子出版 * |
CSND199700333006; 岡 壽士: '画像データを含む電子カルテ・システム' 医療とコンピュータ Medical Care & Computer 第8巻, 19970919, 第32-36頁, 株式会社日本電子出版 * |
CSND199801441007, 加藤 健次郎, "薬剤情報の提供とコンピュータ", 医療とコンピュータ 第8巻 第6号 Medical Care & Computer, 19971220, 第8巻, 第52〜56頁, JP, 株式会社日本電子出版 * |
CSND199801441007; 加藤 健次郎: '薬剤情報の提供とコンピュータ' 医療とコンピュータ 第8巻 第6号 Medical Care & Computer 第8巻, 19971220, 第52〜56頁, 株式会社日本電子出版 * |
CSND200301186009, 清嶋, "ウオッチ流通", 日経情報ストラテジー No.132 NIKKEI INFORMATION STRATEGY, 20030324, 第156〜157頁, JP, 日経BP社 Nikkei Business Publications,Inc. * |
CSND200301186009; 清嶋: 'ウオッチ流通' 日経情報ストラテジー No.132 NIKKEI INFORMATION STRATEGY , 20030324, 第156〜157頁, 日経BP社 Nikkei Business Publications,Inc. * |
JPN6010068277; 岡 壽士: '画像データを含む電子カルテ・システム' 医療とコンピュータ Medical Care & Computer 第8巻, 19970919, 第32-36頁, 株式会社日本電子出版 * |
JPN6010068279; 清嶋: 'ウオッチ流通' 日経情報ストラテジー No.132 NIKKEI INFORMATION STRATEGY , 20030324, 第156〜157頁, 日経BP社 Nikkei Business Publications,Inc. * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11309068B2 (en) | Electronic prescription delivery system and method | |
Melton et al. | Review of community pharmacy services: what is being performed, and where are the opportunities for improvement? | |
Bailey et al. | Advancing best practices for prescription drug labeling | |
Fischer et al. | Academic detailing can play a key role in assessing and implementing comparative effectiveness research findings | |
Freeman et al. | Does a primary care practice pharmacist improve the timeliness and completion of medication management reviews? | |
Kotwani et al. | Access to antibiotics in New Delhi, India: implications for antibiotic policy | |
Vander Stichele et al. | Attitude of the public toward technical package inserts for medication information in Belgium | |
Wasserfallen et al. | Composition and cost of drugs stored at home by elderly patients | |
Wallace et al. | Suitability of written supplemental materials available on the Internet for nonprescription medications | |
Zehra et al. | Brand versus generic dispensing trend for ciprofloxacin 500 mg, levofloxacin 500 mg, and moxifloxacin 400 mg (oral dosage forms) among pharmacies of Karachi, Pakistan | |
Hoskins et al. | Results of a national asthma campaign survey of primary care in Scotland | |
Chao | Evaluating the educational content of direct-to-consumer fulfillment materials | |
JP2007066283A (en) | Commercial medical record | |
JP2007066283A5 (en) | ||
Linder | Improving care for acute respiratory infections: better systems, not better microbiology | |
Fleming Jr | No rest for the weary. | |
Peacock et al. | Patient care services in independent community pharmacies: a descriptive report | |
Figoni et al. | Generic dispensing rates for substitutable drugs prescribed by general practitioners compared with other private ambulatory specialists: A study based on a French national reimbursement database | |
Momodu et al. | Drug Labels And Advertisements: Extent Of Use As Sources Of Drug Information By Healthcare Professionals In Lagos, Nigeria | |
Beavers | Independents protest nationwide | |
Dalawari et al. | An Emergency Department Pilot Study to Save Money for Patients through use of Retail Pharmacy Generic Drug Discount Programs | |
Bond | Using Medicines Information | |
Marley | Electronic prescribing: a personal view | |
Dobscha et al. | Reducing drug costs at a veterans affairs hospital by increasing market-share of generic fluoxetine | |
Muirhead | R. Ph. s playing major role in therapeutic decisions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080723 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080723 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111011 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120309 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20121113 |